1-BOC-吡咯烷-3-甲酸乙酯 | 170844-49-2

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - BOC-氨基酸
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 1-BOC-吡咯烷-3-甲酸乙酯
• 中文别名: 1-BOC-3-吡咯烷甲酸乙酯；N-Boc-3-吡咯烷甲酸乙酯；1-叔丁氧羰基吡咯烷-3-甲酸乙酯；N-Boc-3-乙氧羰基吡咯烷；N-BOC-3-吡咯烷甲酸乙酯；1-Boc-3-吡咯烷甲酸乙酯
• 英文名称: 1-t-butyloxycarbonylpyrrole-3-carboxylic acid ethyl ester
• 英文别名: 1-(tert-butyl) 3-ethyl pyrrolidine-1,3-dicarboxylate；1-tert-butyl 3-ethyl pyrrolidine-1,3-dicarboxylate；1-tert-butyl 3-ethylpyrrolidine-1,3-dicarboxylate；ethyl 1-Boc-3-pyrrolidinecarboxylate；pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester；1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid ethyl ester；1-O-tert-butyl 3-O-ethyl pyrrolidine-1,3-dicarboxylate
• CAS: 170844-49-2
• 化学式: C₁₂H₂₁NO₄
• 分子量: 243.303
• InChiKey: PKDQVUYUWUHNMG-UHFFFAOYSA-N

物化性质

• 沸点：
  305.6±35.0 °C(Predicted)
• 密度：
  1.100±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2933990090
• 危险类别：
  IRRITANT
• 危险标志：
  GHS07
• 危险性描述：
  H302
• 危险性防范说明：
  P301 + P312 + P330

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Ethyl 1-BOC-3-pyrrolidinecarboxylate
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ethyl 1-BOC-3-pyrrolidinecarboxylate
Ingredient name:
CAS number: 170844-49-2

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C12H21NO4
Molecular weight: 243.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-BOC-吡咯烷-3-甲酸乙酯 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 42.5h， 以94%的产率得到1-Boc-3-羟甲基吡咯烷
  参考文献：
  名称：

  [EN] ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES
  [FR] DERIVES ANTIBACTERIENS D'AMINOQUINAZOLIDINEDIONE

  摘要：

  式(I)的化合物中：A是式(II)、式(III)或式(IV)，B是式(V)、式(VI)或式(VII)，可用于各种应用，包括用作抗菌剂。

  公开号：

  WO2005049605A1
• 作为产物：
  描述：

  乙醇 、 1-BOC-吡咯烷-3-甲酸 在 4-二甲氨基吡啶 氯甲酸乙酯 、 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 1-BOC-吡咯烷-3-甲酸乙酯
  参考文献：
  名称：

  [EN] COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING
  [FR] COMPOSÉS ET COMPOSITIONS POUR L'AMÉLIORATION DE LA COGNITION, LEURS PROCÉDÉS DE FABRICATION, ET MÉTHODES DE TRAITEMENT

  摘要：

  揭示了包括噻唑二唑衍生物在内的肌碱激动剂化合物，以及其组合物和制剂。还揭示了合成这种噻唑二唑化合物的方法。进一步揭示了使用这些肌碱激动剂或其药学适宜形式来增强认知功能的治疗方法。

  公开号：

  WO2011085406A1

文献信息

• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2016046530A1

  公开（公告）日：2016-03-31

  The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1). The invention further relates to the use of DUB inhibitors in the treatment of cancer and other indications. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 to R8 are as defined herein.

  本发明涉及新型化合物和制备去泛素化酶（DUBs）抑制剂的方法。具体而言，本发明涉及抑制泛素C端水解酶L1（UCHL1）。本发明进一步涉及在癌症和其他适应症治疗中使用DUB抑制剂。本发明的化合物包括具有式（I）或其药用可接受盐的化合物，其中R1至R8如本文所定义。
• [EN] CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES<br/>[FR] CARBOXAMIDES AZAHÉTÉROCYCLIQUES D'AMINES CYCLIQUES
  申请人：MERCK PATENT GMBH

  公开号：WO2012016001A1

  公开（公告）日：2012-02-02

  The invention provides novel cyclic amine azaheterocyclic carboxamide according to Formula (I), Formula (II) and Formula (III) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

  这项发明提供了根据式(I)、式(II)和式(III)制备的新型环胺氮杂杂环羧酰胺，以及它们用于治疗高增殖性疾病，如癌症的用途。
• [EN] AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES<br/>[FR] INHIBITEURS DE KINASES ASSOCIÉES AUX RÉCEPTEURS D'INTERLEUKINE À BASE D'AMIDOPYRAZOLE
  申请人：MERCK SHARP & DOHME

  公开号：WO2012129258A1

  公开（公告）日：2012-09-27

  This invention relates to amidopyrazole compounds that are inhibitors of Interleukin receptor-associated kinases, in particular IRAK-4, and are useful in the treatment of cellular proliferative diseases, for example, cancer, hyperplasia, restenosis, cardiac hypertrophy, immune disorders and inflammation.

  这项发明涉及抗干扰素受体相关激酶（特别是IRAK-4）的抑制剂——amidopyRAzole化合物，可用于治疗细胞增殖性疾病，例如癌症、增生、再狭窄、心肌肥大、免疫紊乱和炎症。
• [EN] 3-DIARYLMETHYLENES AND USES THEREOF<br/>[FR] 3-DIARYLMÉTHYLÈNES ET LEURS UTILISATIONS
  申请人：ATUX ISKAY LLC

  公开号：WO2021188949A1

  公开（公告）日：2021-09-23

  3-Diarylmethylenes are disclosed. The compounds activate PP2A, suppress oncogenic kinase signaling, and negatively regulate MYC and MYCN in cancer. The compounds also induce FOXO transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.

  3-二芳基亚甲基烯已被披露。这些化合物激活PP2A，抑制致癌激酶信号传导，并在癌症中负调节MYC和MYCN。这些化合物还通过调节PP2A诱导FOXO转录因子转位到细胞核，从而表现出抗增殖效应。它们在治疗各种疾病中很有用，包括作为单药治疗癌症，或与其他药物联合使用以恢复对化疗的敏感性，尤其是在出现耐药性的情况下。
• COMPOUNDS USEFUL AS IMMUNOMODULATORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20170107202A1

  公开（公告）日：2017-04-20

  The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

  本发明公开一般涉及可用作免疫调节剂的化合物。本发明提供了化合物、包含此类化合物的组合物及其使用方法。本发明还涉及包含至少一种根据本发明的化合物的药物组合物，这些药物组合物可用于治疗各种疾病，包括癌症和传染病。